NSN 6505-01-691-4533 · NIIN 016914533 · FSC 6505
NO DASHES 6505016914533
In Stock
ADALIMUMAB INJECTION
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ADALIMUMAB INJECTION, 40 MG/0.8 ML |
| FEAT | SPECIAL FEATURES | HUMIRA IS A TISSUE NECROSIS FACTOR (TNF) BLOCKER INDICATED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS TO REDUCE THE SIGNS AND SYMPTOMS INDUCING MAJOR CLINICAL RESPONSE, INHIBITING THE PROGRESSION OF STRUCTURAL DAMAGE, AND IMPROVING PHYSICAL FUNCTION IN ADULT PATIENTS; HUMIRA IS SUPPLIED IN A CARTON CONTAINING A 1 ML PREFILLED GLASS SYRINGE WITH A FIXED 1/2 INCH NEEDLE, PROVIDING 40 MG/0.8 ML OF HUMIRA; THE NEEDLE COVER MAY CONTAIN NATURAL RUBBER LATEX; INTENDED FOR SUBCUTANEOUS ADMINISTRATION; DO NOT USE BEYOND THE EXPIRATION DATE ON THE CONTAINER; HUMIRA MUST BE REFRIGERATED AT 36 F TO 46 F (2 C TO 8 C); DO NOT FREEZE; DO NOT USE IF FROZEN EVEN IF IT HAS BEEN THAWED. |